"This panel will provide insights into the most recent significant competition law developments in the United States and the European Union affecting pharmaceutical and biotechnology companies. Both in- house and outside counsel will provide perspectives on the recent developments and the most practical way for avoiding issues before they emerge and managing investigations and challenges on both sides of the Atlantic. In addition, a leading FTC enforcer will provide perspectives on enforcement actions and initiatives on the horizon."

Objective1:Educate on the fast-evolving antitrust landscape affecting industry.

Objective2:Identify broader trends in IP law, regulation and legislation reflecting and accelerating these developments.

Objective3:"Discuss practical considerations in anticipating, avoiding, managing and defending against government antitrust investigations and private litigation."